Biolife solutions stock.

Water bath, 37°C CryoStor CD10 (BioLife Solutions, 210102) Scalpel Surgical forceps, scissors 70um strainer (ex. Sigma, CD1-1KT) RPMI 1640 (Invitrogen 11875-093) 50ml conical DNase I (Roche, 10-104-159-001, ... 7. Add 100uL Liberase TL (stock 5mg/mL) to each tube, for final 100ug/mL 8. Macerate the tissues with gentleMACS using the …BioLife Solutions is a leading supplier of class-defining cell and gene therapy bioproduction tools and services. Our tools portfolio includes our proprietary CryoStor® freeze media and ...For the upcoming trading day on Monday, 4th we expect BioLife Solutions to open at $12.82, and during the day (based on 14 day Average True Range), to move ...Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS) is a bioproduction tools and services provider. On November 15, 2023, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed ...

May 10, 2023 · BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ... First, BioLife Solutions, Inc. stock is trading at 1.95x book value of equity, which may or may not represent a value proposition. However, it should also be noted the breakdown of its book value ...The estimated net worth of Marcus Schulz is at least $465,171.85 as of August 25th, 2023. Mr. Schulz owns 42,097 shares of BioLife Solutions stock worth more than $465,172 as of November 2nd. This net worth approximation does not reflect any other investments that Mr. Schulz may own. Learn More about Marcus Schulz's net worth.

BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38. Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and Analyst ...

Complete BioLife Solutions Inc. stock information by Barron's. View real-time BLFS stock price and news, along with industry-best analysis.BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to break-even earnings per share a year ago.Stock Symbol NASDAQ:BLFS ; ... Phone Number 425-402-1400; BioLife Solutions is located in Bothell, Washington, on a high-tech campus that has its roots as a dairy farm. They design, manufacture, and market proprietary and generic cGMP biopreservation media products for cells, tissues, and organs. They also perform contract research and offer ...Four times named as one of the top 100 Companies to work for in Washington state (2022, 2020, 2015, and 2013), BioLife Solutions Inc. is a multi-platform provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets. Learn more.

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 29.17% and 4.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Nov 28, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage ...

If this sounds like the kind of workplace you would thrive in, please have a look at our current openings and apply! Perks of working at BioLife Solutions include: At-market competitive wages. Affordable, high-quality medical, dental and vision insurance for team members and their dependents. 401k matching program. Generous company stock awards. BOTHELL, Wash., April 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an …The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.89% during the next 3 months and, with a 90% probability hold a price between $0.00000328 and $0.0002 at the end of this 3-month period.MAIN SITE. STORE. SolutionsBioLife Solutions, Inc. (BLFS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the ...

Dec 1, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets. BioLife recently disclosed its financial results for the fourth quarter of 2022, showcasing solid revenue growth and a better gross margin. In Q4 2022, the company brought in $44.3 million in ...On November 15, 2023, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed at $12.34 per share. One-month return of BioLife Solutions, Inc. (NASDAQ:BLFS) was 10.28%, and its shares lost 41.93% of ...Consensus BioLife Solutions, Inc. Equities. BLFS. US09062W2044. Market Closed - Nasdaq. Other stock markets.BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced ...

Nov. 4, 2021, 04:05 PM. BOTHELL, Wash., Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (the "Company") (Nasdaq: BLFS), a leading supplier of class-defining bioproduction tools and services ...

If this sounds like the kind of workplace you would thrive in, please have a look at our current openings and apply! Perks of working at BioLife Solutions include: At-market competitive wages. Affordable, high-quality medical, dental and vision insurance for team members and their dependents. 401k matching program. Generous company stock awards.The estimated net worth of Roderick de Greef is at least $463,582.14 as of November 30th, 2022. Mr. de Greef owns 34,314 shares of BioLife Solutions stock worth more than $463,582 as of November 20th. This net worth estimate does not reflect any other investments that Mr. de Greef may own.BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted Net Income per share basis (Non-GAAP) in ...For BioLife Solutions stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BioLife Solutions stock forecast of $65.5, a high forecast of $126.33, and a low forecast of $32.2. The average BioLife Solutions stock forecast 2031 represents a 412.95% increase from the last price of $12.7700004577637.Jun 26, 2020 · Hedge fund activity in BioLife Solutions, Inc. (NASDAQ:BLFS) Heading into the second quarter of 2020, a total of 9 of the hedge funds tracked by Insider Monkey were long this stock, a change of ... BioLife Solutions Is Set To Finally Absorb Its Acquisitions BioLife is a producer of biopreservation media for the CGT industry, which is still in the early innings of significant growth. See why BLFS stock is a Buy.BioLife Solutions, Inc. : News, information and stories for BioLife Solutions, Inc. | Other OTC: | Other OTC

The business earned $33.33 million during the quarter, compared to the consensus estimate of $33.28 million. BioLife Solutions has generated ($2.37) earnings per share over the last year (($2.37) diluted earnings per share). Earnings for BioLife Solutions are expected to grow in the coming year, from ($1.06) to ($0.26) per share.

BioLife Solutions is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. Learn why I rate BLFS stock a hold.

BioLife Solutions, Inc. : News, information and stories for BioLife Solutions, Inc. | Other OTC: | Other OTCFirst, BioLife Solutions, Inc. stock is trading at 1.95x book value of equity, which may or may not represent a value proposition. However, it should also be noted the breakdown of its book value ...16 mar 2023 ... Share this article · Cell Processing platform revenue was $68.5 million, up $23.5 million, or 52%, over 2021. · Freezers and Thaw Systems platform ...Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38. Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and …On November 15, 2023, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed at $12.34 per share. One-month return of BioLife Solutions, Inc. (NASDAQ:BLFS) was 10.28%, and its shares lost 41.93% of ...Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.View BioLife Solutions, Inc BLFS investment & stock information. Get the latest BioLife Solutions, Inc BLFS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Discover historical prices for BLFS stock on Yahoo Finance. View daily, weekly or monthly format back to when BioLife Solutions, Inc. stock was issued.May 10, 2023 · BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ...

BioT™ ULT Transporter maintains samples at -50°C for 24 hours. BioT LN2 Transporter maintains cryogenic temperature at -150°C for approximately 2 hours. Ready to use in approximately 10 minutes. Lightweight, easy to …First, BioLife Solutions, Inc. stock is trading at 1.95x book value of equity, which may or may not represent a value proposition. However, it should also be noted the breakdown of its book value ...Dec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. Instagram:https://instagram. a mark metalscaraway black fridaybest biotech etfscheapest motorcycle insurance in california The estimated net worth of Andrew G. Hinson is at least $207,858.00 as of June 15th, 2021. Mr. Hinson owns 17,675 shares of BioLife Solutions stock worth more than $207,858 as of November 3rd. This net worth approximation does not reflect any other investments that Mr. Hinson may own. Learn More about Andrew G. Hinson's net worth.BOTHELL, Wash., Jan. 17, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced the dates of its 2023 analyst day and upcoming … etrade feehow does groundfloor work Stock. Governance. Analyst Coverage. Company. Company. Company. Press Releases. Events. Leadership. Board of Directors. Scientific Advisory Board. Quality Management System. ... Dr. Mathew was part of the founding team of BioLife Solutions, Inc., and is a co-developer of BioLife’s biopreservation media solutions. He is a co-inventor on ... air conditioning stocks See the latest BioLife Solutions Inc stock price (BLFS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and ...BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.